These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 30880146)
1. In vitro metabolic stability and biotransformation of isosteviol in human and rat liver fractions. Adehin A; Tan KS; Lu Z; Cheng Q; Tan W Drug Metab Pharmacokinet; 2019 Jun; 34(3):194-200. PubMed ID: 30880146 [TBL] [Abstract][Full Text] [Related]
2. Disposition of isosteviol in the rat isolated perfused liver. Jin H; Wang J; Gerber JP; Davey AK Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):593-7. PubMed ID: 20082626 [TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of a new cardioprotective agent, KR-33028 in the human liver microsomes and cryopreserved human hepatocytes. Kim H; Yoon YJ; Kim H; Cha EY; Lee HS; Kim JH; Yi KY; Lee S; Cheon HG; Yoo SE; Lee SS; Shin JG; Liu KH Arch Pharm Res; 2005 Nov; 28(11):1287-92. PubMed ID: 16350857 [TBL] [Abstract][Full Text] [Related]
4. Determination of species-difference in microsomal metabolism of amitriptyline using a predictive MRM-IDA-EPI method. Lee JY; Lee SY; Lee K; Oh SJ; Kim SK Chem Biol Interact; 2015 Mar; 229():109-18. PubMed ID: 25623954 [TBL] [Abstract][Full Text] [Related]
5. Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma. Wen Z; Stern ST; Martin DE; Lee KH; Smith PC Drug Metab Dispos; 2006 Sep; 34(9):1436-42. PubMed ID: 16751262 [TBL] [Abstract][Full Text] [Related]
6. A compartmental approach to isosteviol's disposition in Sprague-Dawley rats. Adehin A; Tan KS; Zou C; Lu Z; Lin Y; Wang D; Cheng Q; Tan W Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):1003-1011. PubMed ID: 31820053 [TBL] [Abstract][Full Text] [Related]
7. Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. Prueksaritanont T; Subramanian R; Fang X; Ma B; Qiu Y; Lin JH; Pearson PG; Baillie TA Drug Metab Dispos; 2002 May; 30(5):505-12. PubMed ID: 11950779 [TBL] [Abstract][Full Text] [Related]
8. Oral and i.v. pharmacokinetics of isosteviol in rats as assessed by a new sensitive LC-MS/MS method. Jin H; Gerber JP; Wang J; Ji M; Davey AK J Pharm Biomed Anal; 2008 Nov; 48(3):986-90. PubMed ID: 18701231 [TBL] [Abstract][Full Text] [Related]
9. The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury. Xu D; Li Y; Wang J; Davey AK; Zhang S; Evans AM Life Sci; 2007 Jan; 80(4):269-74. PubMed ID: 17055001 [TBL] [Abstract][Full Text] [Related]
10. Biotransformation of a novel antimitotic agent, I-387, by mouse, rat, dog, monkey, and human liver microsomes and in vivo pharmacokinetics in mice. Ahn S; Kearbey JD; Li CM; Duke CB; Miller DD; Dalton JT Drug Metab Dispos; 2011 Apr; 39(4):636-43. PubMed ID: 21233217 [TBL] [Abstract][Full Text] [Related]
11. Which hydroxy? Evidence for species differences in the regioselectivity of glucuronidation in rat, dog, and human in vitro systems and dog in vivo. Martin IJ; Lewis RJ; Bernstein MA; Beattie IG; Martin CA; Riley RJ; Springthorpe B Drug Metab Dispos; 2006 Sep; 34(9):1502-7. PubMed ID: 16763016 [TBL] [Abstract][Full Text] [Related]
12. Effect of intestinal glucuronidation in limiting hepatic exposure and bioactivation of raloxifene in humans and rats. Dalvie D; Kang P; Zientek M; Xiang C; Zhou S; Obach RS Chem Res Toxicol; 2008 Dec; 21(12):2260-71. PubMed ID: 19548350 [TBL] [Abstract][Full Text] [Related]
13. Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance. Kemp DC; Fan PW; Stevens JC Drug Metab Dispos; 2002 Jun; 30(6):694-700. PubMed ID: 12019197 [TBL] [Abstract][Full Text] [Related]
14. [In vitro metabolism of daphnetin in rat liver S9 fractions]. Liang SC; Ge GB; Xia YL; Qi XY; Wang AX; Tu CX; Yang L Yao Xue Xue Bao; 2017 Feb; 52(2):291-5. PubMed ID: 29979523 [TBL] [Abstract][Full Text] [Related]
15. Glucuronidation of diflunisal in liver and kidney microsomes of rat and man. Brunelle FM; Verbeeck RK Xenobiotica; 1996 Feb; 26(2):123-31. PubMed ID: 8867997 [TBL] [Abstract][Full Text] [Related]
16. Comparative metabolism and stability of andrographolide in liver microsomes from humans, dogs and rats using ultra-performance liquid chromatography coupled with triple-quadrupole and Fourier transform ion cyclotron resonance mass spectrometry. Zhao HY; Hu H; Wang YT Rapid Commun Mass Spectrom; 2013 Jun; 27(12):1385-92. PubMed ID: 23681817 [TBL] [Abstract][Full Text] [Related]
17. Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes. Darnell M; Breitholtz K; Isin EM; Jurva U; Weidolf L Chem Res Toxicol; 2015 May; 28(5):886-96. PubMed ID: 25803559 [TBL] [Abstract][Full Text] [Related]
18. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. Kumar S; Samuel K; Subramanian R; Braun MP; Stearns RA; Chiu SH; Evans DC; Baillie TA J Pharmacol Exp Ther; 2002 Dec; 303(3):969-78. PubMed ID: 12438516 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry. Song Y; Yang X; Jiang Y; Tu P J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207 [TBL] [Abstract][Full Text] [Related]
20. Hepatic and intestinal glucuronidation of mono(2-ethylhexyl) phthalate, an active metabolite of di(2-ethylhexyl) phthalate, in humans, dogs, rats, and mice: an in vitro analysis using microsomal fractions. Hanioka N; Isobe T; Kinashi Y; Tanaka-Kagawa T; Jinno H Arch Toxicol; 2016 Jul; 90(7):1651-7. PubMed ID: 26514348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]